Merck & Co. CAPE ratio
The current Shiller CAPE Ratio for Merck & Co. Inc is 17.266 (2026-01-09), with an average CAPE of 14.832. The lowest CAPE Ratio was 6.147 on 2009-03-09, and the highest was 23.839 on 2024-03-28.
Merck & Co.’s CAPE ratio is a valuation metric that smooths out earnings volatility by using a 10-year inflation-adjusted average of earnings per share (EPS). A high CAPE ratio may indicate overvaluation, while a low ratio could suggest undervaluation. Given Merck’s exposure to pharmaceutical R&D cycles, regulatory approvals, and patent cliffs, its CAPE ratio can fluctuate significantly. Investors use this metric alongside other valuation tools, such as forward P/E and discounted cash flow (DCF) analysis, to assess long-term investment potential.
CAPE Statistics for Merck & Co. (2006-07-03 to 2026-01-09)
- Current CAPE: 17.266 (-0.42%)
- Min: 6.147 (2009-03-09)
- Max: 23.839 (2024-03-28)
- Mean: 14.832
- Median: 15.399
CAPE vs Forward Returns — Merck & Co.
Merck & Co. Metrics (2016-01-11 → 2026-01-09)
- Current Price: $110.53 (-0.41%)
- YTD Return: 3.83%
- Annualized Volatility YTD: 19.72%
- Average Annual Return: 8.45%
- CAGR: 8.49%
10-Year Performance for Merck & Co. Inc
Cumulative Return
Annual Returns
Quarterly Returns
Rolling Volatility (6M)
Return Distribution & Tail Risk (VaR 95/99)
VaR 95%: %
VaR 99%: %